The potential of pomegranate peel (<em>Punica granatum</em>) in the treatment of obese and glucose-intolerant mice

Authors

  • Mariana Pacífico dos Santos Friolli
  • Mariana Côrrea de Souza
  • Marcela Ramos Sant’Ana
  • Camila Bertuzzo Veiga
  • Camila Ramos
  • Mauricio Ariel Rostagno
  • Dennys Esper Cintra

DOI:

https://doi.org/10.34117/bjdv9n2-214

Keywords:

Obesity, Hepatic Steatosis, pomegranate, punicalagin, ellagic acid, emerging extraction technologies

Abstract

Obesity is a pandemic condition, absolutely out of control. Food assistance is among the main proposals for the management of the disease. Thus, the aim of this study was to evaluate the potential of aqueous pomegranate extract in a model of obesity, glucose intolerance and hepatic steatosis induced by high-fat diet. The pomegranate extract was obtained from the association of green extraction techniques. Through the crude extract containing punicalagin and ellagic acid (main compounds), extracts with isolated fractions of these compounds were obtained. For the experimental study, Swiss mice were subjected to the obesity induction period for eight weeks. After, were treated for another 30 days with crude extract of 250 mg/kg (group HF+[1]EXT); punicalagin extract isolated 8.35 mg/kg (HF+Punica group); isolated extract of ellagic acid 0.208 mg/kg (group HF+EA), via gavage. Both the crude extract and its subfractions reduced the body weight gain for the HF+Punica group (1.1 g); HF+EA (0.92 g) compared to HF, while the HF+EXT showed significant weight loss (P<0.001). In the glycemic parameters, all extracts were able to reduce blood glucose when compared to the group with HF. Histological data of liver tissue showed improvement in hepatic steatosis, mainly in the crude extract group. Therefore, it was possible to demonstrate that the aqueous extract of the pomegranate peel, obtained by innovative extraction techniques, can be a potential strategy for the treatment and control of obesity.

References

Bialonska D, et al. (2010). The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota, Int J Food Microbiol.140(2-3):175-182. DOI:https://doi.org/10.1016/j.ijfoodmicro.2010.03.038.

Buettner R, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types, J Mol Endocrinol. 36 (3): 485-501.DOI: https://doi.org/10.1677/jme.1.01909.

Cintra DE, et al. (2006). Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol. 48(4):628–637. https://doi.org/10.1016/j.jhep.2007.12.017.

Cotrim HP, et al., (2016), Non-alcoholic fatty liver disease Brazilian society of hepatology consensus. Arq Gastroenterol, 53 (2):118 – 122. DOI: https://doi.org/10.1590/S0004-28032016000200013.

Fischer UA, Carle R, Kammerer DR. (2011).Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD–ESI/MSn, Food Chem. 127 (2):807–821. DOI: https://doi.org/10.1016/j.foodchem.2010.12.156.

Gil MI, et al. (2000). Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 48 (10); 4581-4589. DOI: https://doi.org/10.1021/jf000404a.

Harzallah A, et al. (2016). Comparison of potential preventive effects of pomegranate flower, peel and seed oil on insulin resistance and inflammation in high fat and high sucrose diet-induced-obesity mice model. Arch Physiol Biochem. 122 (2):75-87.DOI: https://doi.org/10.3109/13813455.2016.1148053.

Hariri N, Thibault L. (2010). High-fat diet-induced obesity in animal models, Nutr Res Rev. 23 (2):270-299. DOI: https://doi.org/10.1017/S0954422410000168.

Hotamisligil GS. (2017). Inflammation, metaflammation and immunometabolic disorders. Nature, 542 (9 February): 177-185. DOI: 10.1038/nature21363.

Kang I, Buckner T, Shay NF, Gu L,Chung S. (2016). Improvements in Metabolic Health with consumption of Ellagic Acid and subsequent conversion into urolithins: Evidence and Mechanisms. American Society for Nutrition. Adv Nutr. 7:961–972.DOI: https://doi.org/10.3945/an.116.012575.

Lan J, et al. (2009). Transport behavior of ellagic acid of pomegranate leaf tannins and its correlation with total cholesterol alteration in HepG2 cells, Biomed Chromatogr. 23 (5): 531-536. DOI: https://doi.org/10.1002/bmc.1150.

Larrosa M, Tomás-Barberán FA, Espín JC. (2006). The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway, J Nutr Biochem.17(9):611-625.DOI: https://doi.org/10.1016/j.jnutbio.2005.09.004.

Lei F, et al. (2007). Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. Int J obes (Lond). 31:1023-1029. DOI: 10.1038/sj.ijo.0803502.

Long J, et al. (2019). Free ellagic acid bioavailability and bioactivity compared to pomegranate juice. Food Funct. 10 (10): 6582-6588. DOI: 10.1039/c9fo01683j.

Parise ER. (2002). Esteatose hepática: Revisão. Atheros, 13 (2): 52-55.

Polce SA, et al. (2018). Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats. Nutrients, 10 (5): 1-15.DOI:https://doi.org/10.3390/nu10050531.

Ramirez I, Tordoff MG, Friedman MI. (1989). Dietary hyperphagia and obesity: what causes them?, Physiol Behav. 45 (1):163-168. DOI:https://doi.org/10.1016/0031-9384(89)90180-7.

Reeves PG, Nielsen FH, Fahey GC. (1993). AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J Nutr. 123 (11):1939-1951.DOI: https://doi.org/10.1093/jn/123.11.1939.

Santos MP, et al. (2019). Extraction of bioactive compounds from pomegranate peel (Punica granatum L.) with pressurized liquids assisted by ultrasound combined with an expansion gas. Ultrasonics Sonochemistry. 54: 11-17. DOI:https://doi.org/10.1016/j.ultsonch.2019.02.021.

Seeram NP, Lee R, Heber D. (2004). Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice, Clin Chim Acta. 348: 63-68. https://doi.org/10.1016/j.cccn.2004.04.029.

Souza MC, et al. (2020). Isolation of gallic acid, caffeine and flavonols from black tea by on-line coupling of pressurized liquid extraction with an adsorbent for the production of functional bakery products. LWT-Food Science and Technology, 11-17.DOI: https://doi.org/10.1016/j.lwt.2019.108661.

Sumere BR, et al. (2018). Combining pressurized liquids with ultrasound to improve the extraction of phenolic compounds from pomegranate peel (Punica granatum L.).Ultrasonics Sonochemistry, 48: 151-162. DOI:https://doi.org/10.1016/j.ultsonch.2018.05.028.

Van de Sande-Lee S, Velloso LA. (2012). Disfunção hipotalâmica na obesidade. Arq Bras Endocrinol Metab. 56 (6): 341-350. DOI: https://doi.org/10.1590/S0004-27302012000600001.

Yoshimura T et al. (2013). Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-Ay mice. Biochemical and Biophysical Research Communications, 434 (3): 486–491. DOI:https://doi.org/10.1016/j.bbrc.2013.03.100.

Zhao W, et al. (2014). In vitro steatosis hepatic cell model to compare the lipid-lowering effects of pomegranate peel polyphenols with several other plant polyphenols as well as its related cholesterol efflux mechanisms, Toxicol Rep.1:945-954.DOI: https://doi.org/10.1016/j.toxrep.2014.10.013.

Downloads

Published

2023-03-28

How to Cite

Friolli, M. P. dos S., de Souza, M. C., Sant’Ana, M. R., Veiga, C. B., Ramos, C., Rostagno, M. A., & Cintra, D. E. (2023). The potential of pomegranate peel (<em>Punica granatum</em>) in the treatment of obese and glucose-intolerant mice. Brazilian Journal of Development, 9(3), 12220–12241. https://doi.org/10.34117/bjdv9n2-214

Issue

Section

Original Papers